- Home
- Applications
- europe
- diagnostic kit
Diagnostic Kit Product Applications In Europe
2 applications found
Prostate cancer is the fourth most common cancer diagnosis in worldwide, with 1 300 000 new cases and 360 000 deaths in 2018 (Globocan 2018). At the initial diagnosis the disease, more than 60% of cases are diagnosed as localized prostate cancer. Localized prostate cancer can be asymptomatic at the early stage and often has an indolent course that may require only active surveillance. Indolent or aggressive, to treat or not to treat this cancer? This is always the question urologists ask themselves. ...
ByOncoDiag based in Miserey, FRANCE
Bladder cancer is the seventh most common cancer diagnosis in worldwide, with 500 000 new cases and 200 000 deaths in 2018 (Globocan 2018). More than 2.7 million people have a history of bladder cancer worldwide. At the initial diagnosis of bladder cancer, more than 80% of cases are diagnosed as non-muscle-invasive bladder cancer (NMIBC). Due to the very high recurrence rate (>80%), NMIBC patients require lifelong surveillance with periodic follow-up cystoscopy (an unpleasant invasive exam) and urine cytology ...
ByOncoDiag based in Miserey, FRANCE